| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Negotiation > No One Ever Wants to Give Cash Back: You Can Profit! |
|
Main Subject - No One Ever Wants to Give Cash Back: You Can Profit!
I learned this technique from an ancient Umatic (3/4 inch) video cassette. It was produced to assist car dealerships in getting the most money from trade-in sales. According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product I don't know if car dealerships still teach this, but I've never had it fail me, yet. Here is how it works in the video. Someone wants a thousand dollars for their ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in trade-in. It's worth a thousand dollars, but you don't want to pay them a thousand dollars. You only want to pay them six hundred dollars, which they have already lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. turned down. You let them see you think about it and then you pull your money out of your pocket. Into their hand, while counting, you put a one hundred dollar bill here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe , then another, then another, then another . . . you hesitate . . . you slowly give them one more hundred dollar bill . . . and then add one more hundred dollar bil d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro l, and stop. You think about it and then say something like, "No, I'm sorry I know it's worth more than that, but that's all I can afford to pay." You have placed t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc hem in a predicament. They have six hundred dollars in hand. Ready money. Hard cash. You reach out to take it back. What do you think they do? No one ever, ever, ev easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi er wants to give back money. They pull it towards themselves. In that one little action you've made the deal. You just bought their trade-in for six hundred dollars nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically and gave yourself a 40% discount. The first time I used this technique was to buy a gold necklace for my wife. I slowly played out the money and bought the neckla and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ce for my price. I've done this for over twenty years from antique stores and car lots to negotiating tables. The technique works well with variations and for all k ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi inds of transactions. Years ago, I needed to update my video production studio. I saw an ad in a professional video magazine for a complete television studio: two ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a cameras/recorders, two video tape recorders and a controller for editing. They were a few years old, but in tip top condition. They were being offered for about ten dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod percent of their original price. This was a super deal at $21,000. The ad also mentioned O.B.O (or best offer). I knew I could deal with this. I made arrangements cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin to fly from Washington State to Texas. The producer picked me up at the airport and took me to his studio and showed me the equipment. We then went to a restaurant tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen for lunch on the way back to the airport. The equipment was in great condition. It was a super deal. I asked him for his best price. He gave it to me: $16,000. I to t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ld him that was a great price, a fair price, and worth every penny, and I was sure that my partners would agree to that when I explained about the quality of the ma ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust chines when I got back. I then mentioned that I had a money order with me for a price that I was authorized to grant right then, but it was much less than the value y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products of the video equipment. I pushed it over to him with an apology. It was four thousand less than his best price. The money order stayed in Houston. The video equipm . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ent went to Washington. The reason this technique works is because people know how hard it is to find someone who wants to buy what they have, and once they have c elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ash in hand, or a money order, they just can't turn it away. It's easier to complete the deal then it is to turn it down . . . even if it means making a little less tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Competing For Top Talent In A Tight Labor Market Company Research and the Interview Are Interruptions Eating Away Your Time?
|